Peginterferon

基本解釋

De novo combination therapy with peginterferon and nucleoside analogues should also be studied I think.
對于聚乙二醇干擾素與核苷類似物的聯(lián)合初始治療也是需要進一步研究。
The sustained virologic response rate was 79% and 80% in two studies, which was higher than the response rate of 50% with the standard of care with peginterferon plus ribavirin.
在兩項試驗中，持續(xù)的病毒學應答率為79%25和80%25，相比標準治療方案，即長效干擾素聯(lián)合利巴韋林的應答率50%25更高。
Peginterferon alfa -2b was prescribed as subcutaneous injection at a dose of 1. 5 mcg/kg/week for patients with body weight less than 65kg or100mcg/week for patients with body weight more than 65kg for 32 weeks.
對于體重小于65 kg患者;按每周每公斤體重1.;5 mcg哌若欣皮下注射; 體重大于65 kg患者;按每周100mcg給藥;均用藥32周。
However, for a straight relapser who was adequately treated with peginterferon and ribavirin the first time around, giving them the same thing again will result in the same outcome.
人們都在關(guān)注二甲雙胍和吡格列酮，我認為數(shù)據(jù)顯示如果你改善他們的胰島素抵抗，那么你可能會改善他們的應答。
peginterferon alfa-2b
聚乙二醇干擾素